Skip to main content

Table 5 Patient characteristics with impact on total cancer incidence

From: Cancer incidence in type 2 diabetes patients - first results from a feasibility study of the D2C cohort

Variable

HR

95%-CI

Female sex

0.69

[0.65-0.72]

BMI (≥ 30 kg/m2)

0.90

[0.86-0.95]

Diabetes duration more than 2 years

0.79

[0.73-0.86]

Metformin (only)

0.95

[0.90-1.01]

Insulin (including combination with metformin)

1.25

[1.17-1.33]

Analogues (including combination with insulin/metformin)

0.89

[0.79-1.01]